ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Research Reagent/Fmoc-Val-Thr(Psi(Me,Me)pro)-OH
C27H32N2O6
480.6 g/mol
Research Reagent

Fmoc-Val-Thr(Psi(Me,Me)pro)-OH

CAS168216-05-5
Category
Research Reagent
Compound Class
Peptide
Primary Use
Research Compound

This compound is a research reagent used in peptide synthesis. It is a protected amino acid derivative featuring a fluorenylmethoxycarbonyl (Fmoc) protecting group and an oxazolidine ring system.

peptide synthesis researchlaboratory reagent for solid-phase peptide synthesis

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Fmoc-Val-Thr(Psi(Me,Me)pro)-OH?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

StrongStructure SimilarSimilarity 0.85

Fmoc-Ile-Thr(Psi(Me,Me)pro)-OH

CAS957780-52-8

research compound

SimilarStructure SimilarSimilarity 0.83

(4S,5R)-3-(Fmoc-Alaninyl)-2,2,5-trimethyloxazolidine-4-carboxylic acid

CAS252554-79-3

research compound

SimilarStructure SimilarSimilarity 0.81

Fmoc-Thr(tBu)-Thr(Psi(Me,Me)pro)-OH

CAS1676104-73-6

pharmaceutical intermediate

SimilarStructure SimilarSimilarity 0.78

Fmoc-Leu-Thr(Psi(Me,Me)pro)-OH

CAS955048-89-2

research compound

ReferenceSame Category

3,4-Difluorophenylboronic acid

CAS168267-41-2

research compound

ReferenceSame Category

N-(5-bromoquinoxalin-6-yl)guanidine

CAS168329-48-4

research compound

ReferenceSame Category

Beta-Methyl L-aspartate hydrochloride

CAS16856-13-6

research compound

ReferenceSame Category

AC1LCSQ4

CAS16859-59-9

research compound

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

(4S,5R)-3-[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-methylbutanoyl]-2,2,5-trimethyl-1,3-oxazolidine-4-carboxylic acid

InChIKey

OPMOLWFENHTLNA-XARZLDAJSA-N

SMILES

C[C@@H]1[C@H](N(C(O1)(C)C)C(=O)[C@H](C(C)C)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24)C(=O)O

Synonyms (8)
  • Fmoc-Val-Thr(|xMe,Mepro)-OH

Sourcing Fmoc-Val-Thr(Psi(Me,Me)pro)-OH?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→